Demographic Risk Factors for COVID-19 Infection, Severity, ICU Admission and Death: a Meta-analysis of 59 Studies
Overview
Authors
Affiliations
Objective: We aimed to describe the associations of age and sex with the risk of COVID-19 in different severity stages ranging from infection to death.
Design: Systematic review and meta-analysis.
Data Sources: PubMed and Embase through 4 May 2020.
Study Selection: We considered cohort and case-control studies that evaluated differences in age and sex on the risk of COVID-19 infection, disease severity, intensive care unit (ICU) admission and death.
Data Extraction And Synthesis: We screened and included studies using standardised electronic data extraction forms and we pooled data from published studies and data acquired by contacting authors using random effects meta-analysis. We assessed the risk of bias using the Newcastle-Ottawa Scale.
Results: We screened 11.550 titles and included 59 studies comprising 36.470 patients in the analyses. The methodological quality of the included papers was high (8.2 out of 9). Men had a higher risk for infection with COVID-19 than women (relative risk (RR) 1.08, 95% CI 1.03 to 1.12). When infected, they also had a higher risk for severe COVID-19 disease (RR 1.18, 95% CI 1.10 to 1.27), a higher need for intensive care (RR 1.38, 95% CI 1.09 to 1.74) and a higher risk of death (RR 1.50, 95% CI 1.18 to 1.91). The analyses also showed that patients aged 70 years and above have a higher infection risk (RR 1.65, 95% CI 1.50 to 1.81), a higher risk for severe COVID-19 disease (RR 2.05, 95% CI 1.27 to 3.32), a higher need for intensive care (RR 2.70, 95% CI 1.59 to 4.60) and a higher risk of death once infected (RR 3.61, 95% CI 2.70 to 4.84) compared with patients younger than 70 years.
Conclusions: Meta-analyses on 59 studies comprising 36.470 patients showed that men and patients aged 70 and above have a higher risk for COVID-19 infection, severe disease, ICU admission and death.
Prospero Registration Number: CRD42020180085.
Nowak A, Caldinelli A, Segelmark M, Rydell H, Artborg A, Bellocco R Clin Kidney J. 2025; 18(3):sfaf030.
PMID: 40052164 PMC: 11883224. DOI: 10.1093/ckj/sfaf030.
Shergill S, Elshibly M, Hothi S, Parke K, England R, Wormleighton J BMJ Open. 2025; 15(3):e089508.
PMID: 40050066 PMC: 11887317. DOI: 10.1136/bmjopen-2024-089508.
Gomez-Mesa J, Arango-Ibanez J, Perel P, Prabhakaran D, Leon-Giraldo H, Toro-Pedroza A Glob Heart. 2025; 20(1):21.
PMID: 40026348 PMC: 11869830. DOI: 10.5334/gh.1403.
Predictors of developing severe COVID-19 among hospitalized patients: a retrospective study.
Alkhalifa H, Darwish E, Alsalman Z, Alfaraj A, Alkhars A, Alkhalifa F Front Med (Lausanne). 2025; 11:1494302.
PMID: 39895823 PMC: 11784616. DOI: 10.3389/fmed.2024.1494302.
Traore A, Toure M, Coulibaly Y, Keita M, Diarra B, Sanafo S BMC Infect Dis. 2025; 25(1):77.
PMID: 39825241 PMC: 11742798. DOI: 10.1186/s12879-025-10456-x.